Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions.
Ben J MaraisElaine CheongShelanah FernandoSanthosh DanielMatthew R WattsLucinda J BerglundSimone E BarryGeorge KotsiouAlex P HeadleyRichard A StapledonPublished in: Open forum infectious diseases (2020)
We documented dramatic responses to infliximab in 4 tuberculous meningitis cases with severe paradoxical reactions after effective antibacterial treatment, despite high-dose steroids. In every instance, infliximab was used as a last resort after all other options were exhausted, resulting in delayed initiation that may have adversely affected patient outcomes.